4-(Piperazin-1-yl)phenol hydrochloride, 98%, 250mg

(4-(Difluoromethyl)-2-fluorophenyl)methanol, 98%, 1g

(S)-tert-butyl 2-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)pyrrolidine-1-carboxylate, 97%, 1g

2-Bromodithiophene, 97.0%, 1g

Ethyl tert-Butylacetate>99.0%(GC)25mL

N-(4-Nitrobenzoyl)-L-glutamic acid diethyl ester, 98%, 1g

4,4-dimethyl-1-[(1R)-1-phenylethyl]pyrrolidine-2,3,5-trione, 97.0%, 5g

3,5-dibromo-1-(2,2-diethoxyethyl)-1H-1,2,4-triazole, 95.0%, 2g

Ácido tartárico DL, mínimo 99,5 %, anhidro, 100 g, envase de plástico.

N-Benzylacetamide>98.0%(GC)500g

4-Hydroxyindole, 98.0%, 5g

N-(4-Bromo-phenyl)-2-hydroxy-5-iodo-benzamide, 95.0%, 1g

2-(Morpholinothio)benzothiazole>97.0%(GC)25g